Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 6 Seizures 5 Lennox Gastaut Syndrome 3 Epilepsies, Myoclonic 3 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Glioblastoma 1 Gallbladder Neoplasms 1 Epilepsy 1 Colonic Neoplasms 1 Cancer Pain 1 Behavior 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Behavior × Cannabidiol × Clear all

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡